Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Zanesi

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Seminars in Cancer Biology|September 25, 2010
Molecular basis of CLLYuri Pekarsky, Nicola Zanesi, Carlo M Croce
Mutation Research|August 9, 2005
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer preventionNicola Zanesi, Yuri Pekarsky, Carlo M Croce
Hematology/Oncology Clinics of North America|August 25, 2004
Tcl1 as a model for lymphomagenesisYuri Pekarsky, Nicola Zanesi, Rami Aqeilan, et al.
Journal of Cellular Biochemistry|November 30, 2006
Animal models for chronic lymphocytic leukemiaYuri Pekarsky, Nicola Zanesi, Rami I Aqeilan, et al.
The Lancet. Oncology|December 11, 2002
FHIT: from gene discovery to cancer treatment and preventionYuri Pekarsky, Nicola Zanesi, Alexey Palamarchuk, et al.
Journal of Nucleic Acids Investigation|June 14, 2011
MicroRNAs in mouse models of lymphoid malignanciesNicola Zanesi, Yuri Pekarsky, Francesco Trapasso, et al.
Gene Expression|February 21, 2015
The long journey of TCL1 transgenic mice: lessons learned in the last 15 yearsYuri Pekarsky, Alessandra Drusco, Prasanthi Kumchala, et al.
Current Pharmaceutical Design|May 18, 2012
Novel insights in molecular mechanisms of CLLNicola Zanesi, Veronica Balatti, Arianna Bottoni, et al.
Genes, Chromosomes & Cancer|January 21, 2026
Endogenous Processes Underlying Clock-Like Mutational SignaturesTeresa Druck, Rami I Aqeilan, C Marcelo Aldaz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2025
The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2Gerard J Nuovo, Madison Rice, Nicola Zanesi, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Seminars in Cancer Biology|September 25, 2010
Molecular basis of CLLYuri Pekarsky, Nicola Zanesi, Carlo M Croce
Mutation Research|August 9, 2005
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer preventionNicola Zanesi, Yuri Pekarsky, Carlo M Croce
Hematology/Oncology Clinics of North America|August 25, 2004
Tcl1 as a model for lymphomagenesisYuri Pekarsky, Nicola Zanesi, Rami Aqeilan, et al.
Journal of Cellular Biochemistry|November 30, 2006
Animal models for chronic lymphocytic leukemiaYuri Pekarsky, Nicola Zanesi, Rami I Aqeilan, et al.
The Lancet. Oncology|December 11, 2002
FHIT: from gene discovery to cancer treatment and preventionYuri Pekarsky, Nicola Zanesi, Alexey Palamarchuk, et al.
Journal of Nucleic Acids Investigation|June 14, 2011
MicroRNAs in mouse models of lymphoid malignanciesNicola Zanesi, Yuri Pekarsky, Francesco Trapasso, et al.
Gene Expression|February 21, 2015
The long journey of TCL1 transgenic mice: lessons learned in the last 15 yearsYuri Pekarsky, Alessandra Drusco, Prasanthi Kumchala, et al.
Current Pharmaceutical Design|May 18, 2012
Novel insights in molecular mechanisms of CLLNicola Zanesi, Veronica Balatti, Arianna Bottoni, et al.
Genes, Chromosomes & Cancer|January 21, 2026
Endogenous Processes Underlying Clock-Like Mutational SignaturesTeresa Druck, Rami I Aqeilan, C Marcelo Aldaz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2025
The Prevention of Fatal Tauopathy in a Mouse Model of Alzheimer Disease by Blocking BCL2Gerard J Nuovo, Madison Rice, Nicola Zanesi, et al.
Pageof 7